Single-center Open Randomized Clinical Trial to Evaluate Pharmacokinetics, Pharmacodynamics and Safety of Leucostim (JSC "BIOCAD", Russia) Compared to Neupogen (F. Hoffman-La Roche Ltd., Switzerland)

Trial Profile

Single-center Open Randomized Clinical Trial to Evaluate Pharmacokinetics, Pharmacodynamics and Safety of Leucostim (JSC "BIOCAD", Russia) Compared to Neupogen (F. Hoffman-La Roche Ltd., Switzerland)

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 09 May 2016

At a glance

  • Drugs Filgrastim (Primary) ; Filgrastim (Primary)
  • Indications Diabetic neuropathies; Leucocytosis; Neutropenia
  • Focus Pharmacokinetics
  • Sponsors Biocad
  • Most Recent Events

    • 09 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top